皓元医药：2025年前三季度净利润约2.37亿元

Group 1 - The core viewpoint of the article highlights the strong financial performance of Haoyuan Pharmaceutical in Q3 2025, with significant year-on-year growth in revenue and net profit [1] - The company's revenue for the first three quarters of 2025 reached approximately 2.059 billion yuan, representing a year-on-year increase of 27.18% [1] - The net profit attributable to shareholders was around 237 million yuan, showing a substantial year-on-year increase of 65.09% [1] - Basic earnings per share were reported at 1.12 yuan, which is an increase of 64.71% compared to the previous year [1] Group 2 - As of the report date, Haoyuan Pharmaceutical's market capitalization stands at 18 billion yuan [2]